KPIs & Operating Metrics(New)
Growth Metrics

Medtronic (MDT) Shares Outstanding (Weighted Average) (2016 - 2026)

Medtronic (MDT) has disclosed Shares Outstanding (Weighted Average) for 14 consecutive years, with $1.3 billion as the latest value for Q1 2026.

  • Quarterly Shares Outstanding (Weighted Average) changed 0.36% to $1.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Jan 2026, changed 0.36% year-over-year, with the annual reading at $1.3 billion for FY2025, 3.17% down from the prior year.
  • Shares Outstanding (Weighted Average) hit $1.3 billion in Q1 2026 for Medtronic, roughly flat from $1.3 billion in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.3 billion in Q1 2022 to a low of $1.3 billion in Q3 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2022.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 0.08% in 2023 and later fell 3.23% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $1.3 billion in 2022, then grew by 0.07% to $1.3 billion in 2023, then dropped by 3.13% to $1.3 billion in 2024, then dropped by 0.51% to $1.3 billion in 2025, then rose by 0.01% to $1.3 billion in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for MDT at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.